The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price gain of 8.20% this year. Over the last six months, there has been a stronger performance of -17.19%. The price of BMY leaped by -0.32% during the last 30 days period. For the last 5-days stocks have slided -1.37%.
The present stock price for Bristol-Myers Squibb Co (BMY) is $46.69. In the last trading session, the stock made a considerable jump, reaching $68.0 after an opening price of $46.69. The stock briefly fell to $36.0 before ending the session at $47.36.
The market performance of Bristol-Myers Squibb Co’s stock has been turbulent in recent times.
52-week price history of BMY Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Bristol-Myers Squibb Co’s current trading price is -26.28% away from its 52-week high, while its distance from the 52-week low is 12.22%. The stock’s price range during this period has varied between$41.60 and $63.33. The Bristol-Myers Squibb Co’s shares, which operate in the Healthcare, saw a trading volume of around 9.93 million for the day, a figure considerably lower than their average daily volume of 14.83 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Bristol-Myers Squibb Co (BMY) has experienced a quarterly decline of -5.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 95.02B and boasts a workforce of 34100 employees.
Bristol-Myers Squibb Co: Analysts’ Ratings Unveiled
As of right now, 3 analysts are rating Bristol-Myers Squibb Co as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 18 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 51.46, with a change in price of -11.52. Similarly, Bristol-Myers Squibb Co recorded 14,314,754 in trading volume during the last 100 days, posting a change of -19.79%.
BMY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 2.95. Similarly, the long-term debt-to-equity ratio is also 2.73.
BMY Stock Stochastic Average
Bristol-Myers Squibb Co’s raw stochastic average for the past 50 days is presently 39.79%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 21.47%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 49.28% and 49.12%, respectively.
